Status: Not yet recruiting
First in Human Study of ALT-01 in Healthy Participants
The primary objective of the study is to evaluate the safety and tolerability of ALT-01 in healthy participants
Participants needed: 50
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Altis Medicines, IncUpdated: Oct 13, 2026Locations: 1
Eligibility criteria
Willingness to provide written informed consent and comply with the intervention... [+3]
Women who are pregnant or lactating [+3]